Moderna Pre-Tax Income 2017-2024 | MRNA

Moderna pre-tax income for the twelve months ending September 30, 2024 was $-2.353B, a 0.17% decline year-over-year.

  • Moderna annual pre-tax income for 2023 was $-3.942B, a 141.17% decline from 2022.
  • Moderna annual pre-tax income for 2022 was $9.575B, a 27.93% decline from 2021.
  • Moderna annual pre-tax income for 2021 was $13.285B, a 1885.62% decline from 2020.

Moderna Pre-Tax Income 2017-2024 | MRNA

  • Moderna annual pre-tax income for 2023 was $-3.942B, a 141.17% decline from 2022.
  • Moderna annual pre-tax income for 2022 was $9.575B, a 27.93% decline from 2021.
  • Moderna annual pre-tax income for 2021 was $13.285B, a 1885.62% decline from 2020.